Product NDC: | 0013-1114 |
Proprietary Name: | Cyklokapron |
Non Proprietary Name: | TRANEXAMIC ACID |
Active Ingredient(s): | 100 mg/mL & nbsp; TRANEXAMIC ACID |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0013-1114 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019281 |
Marketing Category: | NDA |
Start Marketing Date: | 19861230 |
Package NDC: | 0013-1114-10 |
Package Description: | 10 AMPULE in 1 BOX (0013-1114-10) > 10 mL in 1 AMPULE (0013-1114-01) |
NDC Code | 0013-1114-10 |
Proprietary Name | Cyklokapron |
Package Description | 10 AMPULE in 1 BOX (0013-1114-10) > 10 mL in 1 AMPULE (0013-1114-01) |
Product NDC | 0013-1114 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TRANEXAMIC ACID |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19861230 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | TRANEXAMIC ACID |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |